{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T08:43:12Z","timestamp":1794040992426,"version":"4.8.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023410","name":"Snow Medical Research Foundation","doi-asserted-by":"publisher","award":["2022\/SF167"],"award-info":[{"award-number":["2022\/SF167"]}],"id":[{"id":"10.13039\/501100023410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1154265"],"award-info":[{"award-number":["1154265"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1135955"],"award-info":[{"award-number":["1135955"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1125656"],"award-info":[{"award-number":["1125656"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1132975"],"award-info":[{"award-number":["1132975"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1077636"],"award-info":[{"award-number":["1077636"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1181932"],"award-info":[{"award-number":["1181932"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1141278"],"award-info":[{"award-number":["1141278"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1134989"],"award-info":[{"award-number":["1134989"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["290208"],"award-info":[{"award-number":["290208"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2016792"],"award-info":[{"award-number":["2016792"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020480","name":"CSL Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018936","name":"Universit\u00e4tsklinikum Heidelberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018936","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ebiom.2024.105419","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T06:09:50Z","timestamp":1730095790000},"page":"105419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Heterogeneity of the human immune response to malaria infection and vaccination driven by latent cytomegalovirus infection"],"prefix":"10.1016","volume":"109","author":[{"given":"Reena","family":"Mukhiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2480-0614","authenticated-orcid":false,"given":"Wim A.","family":"Fleischmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Loughland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anne","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"de Labastida Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Beeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1066-7960","authenticated-orcid":false,"given":"Bridget E.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alejandro","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Engwerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8378-9497","authenticated-orcid":false,"given":"Richard","family":"Thomson-Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0268-232X","authenticated-orcid":false,"given":"Michelle J.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2024.105419_bib1","series-title":"World malaria report 2023","year":"2023"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105419_bib2","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1042\/BST20230401","article-title":"Mature beyond their years: young children who escape detection of parasitemia despite living in settings of intense malaria transmission","volume":"52","author":"Holla","year":"2024","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ebiom.2024.105419_bib3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S1473-3099(15)00239-X","article-title":"Immunogenicity of the RTS,S\/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial","volume":"15","author":"White","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105419_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1473-3099(13)70005-7","article-title":"Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data","volume":"13","author":"Bejon","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105419_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41577-023-00941-2","article-title":"Immunological factors linked to geographical variation in vaccine responses","volume":"24","author":"van Dorst","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2024.105419_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4269\/ajtmh.17-1014","article-title":"Safety, immunogenicity, and protective efficacy against controlled human malaria infection of Plasmodium falciparum sporozoite vaccine in Tanzanian adults","volume":"99","author":"Jongo","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ebiom.2024.105419_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199701093360202","article-title":"A\u00a0preliminary evaluation of a recombinant circumsporozoite protein vaccine against plasmodium falciparum malaria","volume":"336","author":"Stoute","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2024.105419_bib8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/318534","article-title":"Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental plasmodium falciparum malaria","volume":"183","author":"Kester","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105419_bib9","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1016\/j.vaccine.2007.05.005","article-title":"A\u00a0phase I\/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S\/AS02A in malaria-na\u00efve adults","volume":"25","author":"Kester","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2024.105419_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006465","article-title":"Evaluation of RTS,S\/AS02A and RTS,S\/AS01B in adults in a high malaria transmission area","volume":"4","author":"Polhemus","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2024.105419_bib11","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/14760584.2021.1981864","article-title":"Multi-functional antibody profiling for malaria vaccine development and evaluation","volume":"20","author":"Opi","year":"2021","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105419_bib12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.immuni.2024.05.001","article-title":"Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge","volume":"57","author":"Nkumama","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2024.105419_bib13","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T\u00a0follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2024.105419_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/oxfimm\/iqab008","article-title":"T-follicular helper cells in malaria infection and roles in antibody induction","volume":"2","author":"Soon","year":"2021","journal-title":"Oxf Open Immunol"},{"key":"10.1016\/j.ebiom.2024.105419_bib15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.it.2021.04.006","article-title":"Cytokine-skewed Tfh cells: functional consequences for B cell help","volume":"42","author":"Olatunde","year":"2021","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ebiom.2024.105419_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.pt.2012.09.001","article-title":"Experimentally induced blood stage malaria infection as a tool for clinical research","volume":"28","author":"Engwerda","year":"2012","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ebiom.2024.105419_bib17","article-title":"Th2-like T follicular helper cells promote functional antibody production during Plasmodium falciparum infection","volume":"1","author":"Chan","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ebiom.2024.105419_bib18","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41590-020-0678-5","article-title":"Infection-induced plasmablasts are a nutrient sink that impairs humoral immunity to malaria","volume":"21","author":"Vijay","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2024.105419_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103784","article-title":"Adults with plasmodium falciparum malaria have higher magnitude and quality of circulating T-follicular helper cells compared to children","volume":"75","author":"Oyong","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2024.105419_bib20","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1038\/s41467-022-31880-6","article-title":"Age-dependent changes in circulating Tfh cells influence development of functional malaria antibodies in children","volume":"13","author":"Chan","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105419_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2249.2008.03785.x","article-title":"Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals","volume":"155","author":"Chidrawar","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ebiom.2024.105419_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2014.12.020","article-title":"Variation in the human immune system is largely driven by non-heritable influences","volume":"160","author":"Brodin","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2024.105419_bib23","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.4049\/jimmunol.1800171","article-title":"Cytomegalovirus: shape-shifting the immune system","volume":"200","author":"Picarda","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ebiom.2024.105419_bib24","first-page":"367","article-title":"T\u00a0cell responses to cytomegalovirus","volume":"16","author":"Klenerman","year":"2016","journal-title":"Nat\u00a0Rev Immunol"},{"key":"10.1016\/j.ebiom.2024.105419_bib25","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1128\/JVI.01262-06","article-title":"The cytomegalovirus-specific CD4\u00a0+ T-cell response expands with age and markedly alters the CD4\u00a0+ T-cell repertoire","volume":"81","author":"Pourgheysari","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2024.105419_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2405","article-title":"Indirect effects of cytomegalovirus infection: implications for vaccine development","volume":"33","author":"Moseley","year":"2023","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.ebiom.2024.105419_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.ebiom.2024.105419_bib28","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/586715","article-title":"Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in the Gambia","volume":"197","author":"Kaye","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105419_bib29","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200004","article-title":"Reduced Ebola vaccine responses in CMV+ young adults is associated with expansion of CD57+KLRG1+ T cells","volume":"217","author":"Bowyer","year":"2020","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ebiom.2024.105419_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41541-020-0160-2","article-title":"Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial","volume":"5","author":"Blank","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ebiom.2024.105419_bib31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41541-023-00701-2","article-title":"Multifunctional IgG\/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine","volume":"8","author":"Rosenkranz","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ebiom.2024.105419_bib32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2567.2007.02787.x","article-title":"Cytomegalovirus infection induces T-cell differentiation without impairing antigen-specific responses in Gambian infants","volume":"124","author":"Miles","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.ebiom.2024.105419_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021914","article-title":"A\u00a0pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs","volume":"6","author":"McCarthy","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2024.105419_bib34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1475-2875-10-48","article-title":"A\u00a0real-time, quantitative PCR method using hydrolysis probes for the monitoring of plasmodium falciparum load in experimentally infected human volunteers","volume":"10","author":"Rockett","year":"2011","journal-title":"Malar J"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105419_bib35","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S1473-3099(19)30611-5","article-title":"Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium\u00a0falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a\/b trial","volume":"20","author":"Gaur","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105419_bib36","doi-asserted-by":"crossref","first-page":"e657","DOI":"10.1093\/cid\/ciaa368","article-title":"A\u00a0phase 1, placebo controlled, randomised, single ascending dose study and a volunteer infection study to characterize the safety, pharmacokinetics and antimalarial activity of the Plasmodium phosphatidylinositol 4-kinase inhibitor MMV390048","volume":"71","author":"McCarthy","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105419_bib37","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI98012","article-title":"A\u00a0controlled human malaria infection model enabling evaluation of transmission-blocking interventions","volume":"128","author":"Collins","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ebiom.2024.105419_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024413","article-title":"A\u00a0phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide\u00ae ISA 720","volume":"6","author":"McCarthy","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2024.105419_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the human immunology project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2024.105419_bib40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.immuni.2015.02.012","article-title":"Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria","volume":"42","author":"Boyle","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2024.105419_bib41","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1741-7015-12-108","article-title":"Opsonic phagocytosis of plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria","volume":"12","author":"Osier","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.ebiom.2024.105419_bib42","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41467-021-21998-4","article-title":"Mechanisms and targets of Fc\u03b3-receptor mediated immunity to malaria sporozoites","volume":"12","author":"Feng","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105419_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102727","article-title":"Persistent expansion and Th1-like skewing of HIV-specific circulating T follicular helper cells during antiretroviral therapy","volume":"54","author":"Niessl","year":"2020","journal-title":"eBioMedicine"},{"issue":"15","key":"10.1016\/j.ebiom.2024.105419_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93434","article-title":"Dichotomous miR expression and immune responses following primary blood-stage malaria","volume":"2","author":"Burel","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2024.105419_bib45","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11357-013-9557-4","article-title":"Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults","volume":"36","author":"Turner","year":"2014","journal-title":"Age"},{"key":"10.1016\/j.ebiom.2024.105419_bib46","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.vaccine.2015.01.071","article-title":"Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine","volume":"33","author":"Frasca","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2024.105419_bib47","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1016\/S0264-410X(03)00309-8","article-title":"Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination\u2014an impact of immunosenescence","volume":"21","author":"Trzonkowski","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2024.105419_bib48","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.vaccine.2012.11.041","article-title":"Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination","volume":"31","author":"Derhovanessian","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2024.105419_bib49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbi.2016.09.025","article-title":"Cytomegalovirus serostatus, inflammation, and antibody response to influenza vaccination in older adults: the moderating effect of beta blockade","volume":"61","author":"Reed","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.ebiom.2024.105419_bib50","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1128\/JVI.02425-12","article-title":"Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system","volume":"87","author":"Arias","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2024.105419_bib51","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11357-011-9240-6","article-title":"Relationship between functional ability in older people, immune system status, and intensity of response to CMV","volume":"34","author":"Moro-Garc\u00eda","year":"2012","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.ebiom.2024.105419_bib52","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/jmv.23642","article-title":"Impact of human cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults","volume":"85","author":"Wald","year":"2013","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.ebiom.2024.105419_bib53","first-page":"1163","article-title":"Cytomegalovirus seropositivity predicts a decline in the T cell but not the antibody response to influenza in vaccinated older adults independent of type 2 diabetes status","volume":"72","author":"Haq","year":"2017","journal-title":"J\u00a0Gerontol A Biol Sci M\u00e9d Sci"},{"key":"10.1016\/j.ebiom.2024.105419_bib54","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1016\/j.vaccine.2011.03.086","article-title":"Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities","volume":"29","author":"den Elzen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2024.105419_bib55","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3109\/23744235.2015.1135252","article-title":"Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4\/CD8 ratio","volume":"48","author":"Strindhall","year":"2016","journal-title":"Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105419_bib56","doi-asserted-by":"crossref","first-page":"281ra43","DOI":"10.1126\/scitranslmed.aaa2293","article-title":"Cytomegalovirus infection enhances the immune response to influenza","volume":"7","author":"Furman","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2024.105419_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2015-000140","article-title":"Predictors of the antibody response to influenza vaccination in older adults with type 2 diabetes","volume":"3","author":"McElhaney","year":"2015","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.ebiom.2024.105419_bib58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fimmu.2018.00082","article-title":"Negative effect of age, but not of latent cytomegalovirus infection on the antibody response to a novel influenza vaccine strain in healthy adults","volume":"9","author":"van den Berg","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2024.105419_bib59","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.4049\/jimmunol.1403080","article-title":"Impaired NK cell responses to pertussis and H1N1 influenza vaccine antigens in human cytomegalovirus-infected individuals","volume":"194","author":"Nielsen","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ebiom.2024.105419_bib60","doi-asserted-by":"crossref","first-page":"ofad063","DOI":"10.1093\/ofid\/ofad063","article-title":"Association of cytomegalovirus serostatus with severe acute respiratory syndrome coronavirus 2 vaccine responsiveness in nursing home residents and healthcare workers","volume":"10","author":"Freeman","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105419_bib61","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3389\/fimmu.2018.01660","article-title":"CXCR3+ T follicular helper cells induced by Co-administration of RTS,S\/AS01B and viral-vectored vaccines are associated with reduced immunogenicity and efficacy against malaria","volume":"9","author":"Bowyer","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105419_bib62","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.medj.2021.03.014","article-title":"Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination","volume":"2","author":"Minassian","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.ebiom.2024.105419_bib63","article-title":"Protein\/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors","volume":"2","author":"Nielsen","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ebiom.2024.105419_bib64","doi-asserted-by":"crossref","first-page":"176ra32","DOI":"10.1126\/scitranslmed.3005191","article-title":"Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination","volume":"5","author":"Bentebibel","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2024.105419_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/srep26494","article-title":"ICOS+PD-1+CXCR3+ T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination","volume":"6","author":"Bentebibel","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2024.105419_bib66","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/infdis\/jiy639","article-title":"Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen in healthy adults in the United Kingdom and Senegal","volume":"219","author":"Venkatraman","year":"2018","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105419_bib67","article-title":"Differences in anti malarial antibody concentrations and specificities between male and female ugandan children","volume":"2","author":"Apio","year":"2020","journal-title":"Arch Immunol"},{"key":"10.1016\/j.ebiom.2024.105419_bib68","first-page":"16","article-title":"The evolution of greater humoral immunity in\u00a0females than males: implications for vaccine efficacy","volume":"6","author":"Fink","year":"2018","journal-title":"Curr Opin\u00a0Physiology"},{"key":"10.1016\/j.ebiom.2024.105419_bib69","first-page":"626","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat\u00a0Rev Immunol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:38:10Z","timestamp":1778873890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424004559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":69,"alternative-id":["S2352396424004559"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105419","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.04.28.591548","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneity of the human immune response to malaria infection and vaccination driven by latent cytomegalovirus infection","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105419","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105419"}}